-+ 0.00%
-+ 0.00%
-+ 0.00%

Aclaris Therapeutics completes enrollment of 109 patients in Phase 2 bosakitug trial for atopic dermatitis

Reuters·03/18/2026 10:55:15

Please log in to view news